表紙
市場調查報告書

普拿疼的全球市場:2020年∼2024年

Global Paracetamol Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 934859
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
普拿疼的全球市場:2020年∼2024年 Global Paracetamol Market 2020-2024
出版日期: 2020年05月02日內容資訊: 英文 120 Pages
簡介

全球普拿疼市場在2020年∼2024年的預測期間內,預計將以8%的年複合成長率增長,達到4億8,477萬美元的規模。市場成長的主要因素有普拿疼作為API(醫藥品有效成分)大幅用在多數OTC藥上,普拿疼廣泛用作對症緩解的一線治療,而普拿疼在COVID-19疫情中作為退燒藥,更擴大了它的用途。

本報告提供全球普拿疼市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年∼2024年的預測

波特的五力分析

各類型市場區隔

  • 市場區隔
  • 各類型比較:市場規模、預測(2019年∼2024年)
  • 粉末
  • 顆粒
  • 各類型的市場機會

客戶形勢

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模、預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 市場課題
  • 市場趨勢

業者情勢

  • 業者情勢
  • 創造性破壞狀況
  • 競爭模式

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Anhui BBCA Likang Pharmaceutical Co. Ltd.
  • Anqiu Luan Pharmaceutical Co. Ltd.
  • ATABAY KIMYA SANAYI TICARET AS
  • Farmson Pharmaceutical Gujarat Pvt. Ltd.
  • Granules India Ltd.
  • Hebei Jiheng (Group) Pharmaceutical Co. Ltd.
  • Mallinckrodt Plc
  • Meghmani Group
  • SEQENS GROUP
  • Zhejiang Kangle Pharmaceutical Co. Ltd.

附錄

目錄
Product Code: IRTNTR43468

Technavio has been monitoring the paracetamol market and it is poised to grow by $ 484.77 mn during 2020-2024 progressing at a CAGR of 8% during the forecast period. Our reports on paracetamol market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the significant use of paracetamol as an API in large number of OTC drugs, wide application of paracetamol as a first line-therapy for symptomatic relief and growing use of paracetamol as an antipyretic in COVID-19 pandemic. In addition, significant use of paracetamol as an API in large number of OTC drugs is anticipated to boost the growth of the market as well.

The paracetamol market analysis includes type segment and geographic landscapes

Technavio's ‘ paracetamol market ’ is segmented as below:

By Type:

  • Powder
  • Granules

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the growing number of approvals for paracetamol-based combinations as one of the prime reasons driving the paracetamol market growth during the next few years. Also, increasing healthcare expenditure and developments in new paracetamol applications

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our paracetamol market covers the following areas:

  • Paracetamol market sizing
  • Paracetamol market forecast
  • Paracetamol market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading paracetamol market vendors that include Anhui BBCA Likang Pharmaceutical Co. Ltd., Anqiu Luan Pharmaceutical Co. Ltd., ATABAY KIMYA SANAYI TICARET AS, Farmson Pharmaceutical Gujarat Pvt. Ltd., Granules India Ltd., Hebei Jiheng (Group) Pharmaceutical Co. Ltd., Mallinckrodt Plc, Meghmani Group, SEQENS GROUP, and Zhejiang Kangle Pharmaceutical Co. Ltd.. Also, the paracetamol market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • Powder - Market size and forecast 2019-2024
  • Granules - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume driver - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Vendor landscape
  • Landscape disruption
  • Competitive Scenario

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Anhui BBCA Likang Pharmaceutical Co. Ltd.
  • Anqiu Luan Pharmaceutical Co. Ltd.
  • ATABAY KIMYA SANAYI TICARET AS
  • Farmson Pharmaceutical Gujarat Pvt. Ltd.
  • Granules India Ltd.
  • Hebei Jiheng (Group) Pharmaceutical Co. Ltd.
  • Mallinckrodt Plc
  • Meghmani Group
  • SEQENS GROUP
  • Zhejiang Kangle Pharmaceutical Co. Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: Type - Market share 2019-2024 (%)
  • 22: Comparison by Type
  • 23: Powder - Market size and forecast 2019-2024 ($ million)
  • 24: Powder - Year-over-year growth 2019-2024 (%)
  • 25: Granules - Market size and forecast 2019-2024 ($ million)
  • 26: Granules - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by Type
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Overview
  • 48: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Product and service
  • 49: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key offerings
  • 50: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Key customers
  • 51: Anhui BBCA Likang Pharmaceutical Co. Ltd. - Segment focus
  • 52: Anqiu Luan Pharmaceutical Co. Ltd. - Overview
  • 53: Anqiu Luan Pharmaceutical Co. Ltd. - Product and service
  • 54: Anqiu Luan Pharmaceutical Co. Ltd. - Key offerings
  • 55: Anqiu Luan Pharmaceutical Co. Ltd. - Key customers
  • 56: Anqiu Luan Pharmaceutical Co. Ltd. - Segment focus
  • 57: ATABAY KIMYA SANAYI TICARET AS - Overview
  • 58: ATABAY KIMYA SANAYI TICARET AS - Product and service
  • 59: ATABAY KIMYA SANAYI TICARET AS - Key offerings
  • 60: ATABAY KIMYA SANAYI TICARET AS - Key customers
  • 61: ATABAY KIMYA SANAYI TICARET AS - Segment focus
  • 62: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Overview
  • 63: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Product and service
  • 64: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key offerings
  • 65: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Key customers
  • 66: Farmson Pharmaceutical Gujarat Pvt. Ltd. - Segment focus
  • 67: Granules India Ltd. - Overview
  • 68: Granules India Ltd. - Business segments
  • 69: Granules India Ltd. - Key offerings
  • 70: Granules India Ltd. - Key customers
  • 71: Granules India Ltd. - Segment focus
  • 72: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Overview
  • 73: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Product and service
  • 74: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key offerings
  • 75: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Key customers
  • 76: Hebei Jiheng (Group) Pharmaceutical Co. Ltd. - Segment focus
  • 77: Mallinckrodt Plc - Overview
  • 78: Mallinckrodt Plc - Business segments
  • 79: Mallinckrodt Plc - Key offerings
  • 80: Mallinckrodt Plc - Key customers
  • 81: Mallinckrodt Plc - Segment focus
  • 82: Meghmani Group - Overview
  • 83: Meghmani Group - Business segments
  • 84: Meghmani Group - Key offerings
  • 85: Meghmani Group - Key customers
  • 86: Meghmani Group - Segment focus
  • 87: SEQENS GROUP - Overview
  • 88: SEQENS GROUP - Business segments
  • 89: SEQENS GROUP - Key offerings
  • 90: SEQENS GROUP - Key customers
  • 91: SEQENS GROUP - Segment focus
  • 92: Zhejiang Kangle Pharmaceutical Co. Ltd. - Overview
  • 93: Zhejiang Kangle Pharmaceutical Co. Ltd. - Product and service
  • 94: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key offerings
  • 95: Zhejiang Kangle Pharmaceutical Co. Ltd. - Key customers
  • 96: Zhejiang Kangle Pharmaceutical Co. Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations